Form 4 for NUVB Nuvation Bio Inc.
Accepted 2026-04-21 16:35:16 ET · period of report 2026-04-17 · accession 0001369453-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-21 16:35 | 2026-04-17 | NUVB | Wentworth Kerry | Chief REGULATORY Off | M - OptEx | $2.93 | +36.8K | 89.8K | +69% | +$107.7K |
| DT | 2026-04-21 16:35 | 2026-04-17 | NUVB | Wentworth Kerry | Chief REGULATORY Off | S - Sale+OE | $5.01 | -36.8K | 53.0K | -41% | -$184.3K |
| DT | 2026-04-21 16:35 | 2026-04-17 | NUVB | Wentworth Kerry | Chief REGULATORY Off | M - OptEx | $0.00 | -36.8K | 215.2K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-04-17 | M | A | 36,750 | $2.93 | 89,750 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-04-17 | S | D | 36,750 | $5.01 | 53,000 | D | — | — | (F1) Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.05. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-04-17 | M | D | 36,750 | $0.00 | 215,250 | D | $2.93 · — to 2032-08-28 | 36,750 Class A Common Stock | (F3) Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. |